Correlation Between Bellring Brands and Enorama Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bellring Brands and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellring Brands and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellring Brands LLC and Enorama Pharma AB, you can compare the effects of market volatilities on Bellring Brands and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellring Brands with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellring Brands and Enorama Pharma.

Diversification Opportunities for Bellring Brands and Enorama Pharma

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bellring and Enorama is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Bellring Brands LLC and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Bellring Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellring Brands LLC are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Bellring Brands i.e., Bellring Brands and Enorama Pharma go up and down completely randomly.

Pair Corralation between Bellring Brands and Enorama Pharma

Given the investment horizon of 90 days Bellring Brands is expected to generate 1.21 times less return on investment than Enorama Pharma. But when comparing it to its historical volatility, Bellring Brands LLC is 5.0 times less risky than Enorama Pharma. It trades about 0.14 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  419.00  in Enorama Pharma AB on August 29, 2024 and sell it today you would lose (58.00) from holding Enorama Pharma AB or give up 13.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Bellring Brands LLC  vs.  Enorama Pharma AB

 Performance 
       Timeline  
Bellring Brands LLC 

Risk-Adjusted Performance

35 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bellring Brands LLC are ranked lower than 35 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental drivers, Bellring Brands reported solid returns over the last few months and may actually be approaching a breakup point.
Enorama Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enorama Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bellring Brands and Enorama Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bellring Brands and Enorama Pharma

The main advantage of trading using opposite Bellring Brands and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellring Brands position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.
The idea behind Bellring Brands LLC and Enorama Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios